11.4 CMS, The Joint Commission, CDC, ASPEN & ASHP: Standards Beyond USP and FDA
Key Takeaways
CMS Conditions of Participation require hospital drugs to be prepared and administered under federal and state law and accepted standards of practice (42 CFR 482.25), and require infection prevention and antibiotic stewardship programs (42 CFR 482.42). Surveyors treat USP <797> as an accepted compounding standard.
The Joint Commission surveys medication preparation under its Medication Management standards. Since January 1, 2026, its National Performance Goals (which replaced the National Patient Safety Goals for hospitals) still require labeling of all medications and solutions on and off the sterile field, and it offers an optional Medication Compounding Certification.
CDC injection safety guidance limits single-dose vials to one patient. Multiple-dose vials should be dedicated to one patient whenever possible; if used for more than one, they stay in a centralized medication area.
ASPEN's parenteral nutrition safety recommendations cover standardized order and label formats, pharmacist order review, compounding, filters (1.2 µm for lipid-containing PN) and monitoring.
When standards overlap, follow the most stringent applicable requirement. USP chapters are minimums, and state law or accreditation standards may add to them.
11.4 CMS, The Joint Commission, CDC, ASPEN & ASHP: Standards Beyond USP and FDA
The BCSCP outline names USP, FDA, CMS, CDC, ASPEN and TJC in task 3B4. USP chapters and FDA law are covered in 1.2 and 11.1-11.2. This section covers the other standard-setters that shape a sterile compounding program, and how their requirements fit together.
CMS: Conditions of Participation
The Centers for Medicare & Medicaid Services (CMS) sets the Conditions of Participation (CoPs) a hospital must meet to bill Medicare and Medicaid. State survey agencies and CMS-approved accreditors, such as The Joint Commission, check compliance.
- Pharmaceutical services, 42 CFR 482.25: Drugs and biologicals must be controlled and distributed under federal and state law and accepted standards of practice, and compounding is done by or under the supervision of a pharmacist. CMS interpretive guidance treats USP <797> as the accepted professional standard for sterile compounding, so gaps against USP <797> can become hospital survey deficiencies.
- Infection prevention and control and antibiotic stewardship, 42 CFR 482.42: Hospitals must run active infection prevention and antibiotic stewardship programs. CSP-related infections and CLABSI surveillance fall within them.
- Other provider types, such as ambulatory surgery centers (42 CFR Part 416) and home health agencies, have their own CoPs that also reach medication preparation and infection control.
Serious CoP deficiencies can end in termination of Medicare participation, which gives hospital leaders a strong reason to fund compounding compliance.
The Joint Commission (TJC)
| Area | What TJC expects |
|---|---|
| Medication Management (MM) standards | Safe medication preparation, including sterile compounding in appropriate environments with proper technique; labeling; storage; high-alert drug safeguards |
| National Performance Goals (NPGs) | Since January 1, 2026, the NPG chapter has replaced the National Patient Safety Goals (NPSGs) for hospitals and critical access hospitals. The medication goals keep the long-standing requirements, formerly NPSG.03.04.01 and 03.05.01, to label all medications, containers and solutions on and off the sterile field and to reduce harm from anticoagulant therapy |
| Infection control standards | Surveillance, prevention and outbreak response, linked to compounding practices |
| Survey method | Tracers that follow patients and processes, with direct observation (see 10.7) |
| Medication Compounding Certification | An optional certification for organizations that compound, built on USP <795>, <797> and <800> |
CDC: infection prevention guidance
- Injection safety (Core Infection Prevention Practices and the One & Only Campaign):
- use a new needle and syringe for every injection;
- single-dose vials are for one patient;
- multiple-dose vials should be dedicated to one patient whenever possible;
- if a multiple-dose vial must be used for more than one patient, keep it in a centralized medication area and never take it into the immediate patient treatment area.
- Guidelines for the Prevention of Intravascular Catheter-Related Infections (2011, with later updates): maximal sterile barriers at insertion, chlorhexidine-alcohol skin antisepsis, hub disinfection, prompt removal of unneeded lines, and hang times, for example completing lipid emulsion infusions within 12 hours and PN within 24 hours (see 5.4).
- NIOSH (part of CDC) publishes the hazardous drug list that USP <800> relies on (see 6.4).
- CDC also investigates compounding-linked outbreaks, as it did for the 2012 NECC outbreak with 753 cases and 64 deaths.
ASPEN: parenteral nutrition safety
The American Society for Parenteral and Enteral Nutrition (ASPEN) publishes PN safety consensus recommendations and clinical guidelines that pharmacists apply every day:
- Standardized PN ordering (order templates, units per day or per kilogram) and a standardized PN label format that matches the order
- Pharmacist review of every PN order for dose, compatibility and access
- Compounding practices: validated ACD sequences, calcium gluconate as the preferred calcium salt, calcium-phosphate solubility checks, and verifying the aqueous phase before lipid is added in total nutrient admixtures
- Filters: 1.2 µm for lipid-containing PN and 0.2 µm for dextrose-amino acid PN
- Monitoring and special risks: refeeding syndrome (2020 consensus), glucose, electrolytes, triglycerides, liver tests
ASHP and ISMP
- ASHP guidelines on compounding sterile preparations, handling hazardous drugs, preventing chemotherapy errors and managing drug shortages. These are practice standards that surveyors and courts treat as benchmarks.
- ASHP Standardize 4 Safety: national standard concentrations for continuous infusions and compounded oral liquids (see 9.7).
- ISMP: guidelines for safe preparation of compounded sterile preparations, Targeted Medication Safety Best Practices (for example vinca alkaloids in minibags), and high-alert medication lists (see 9.4).
State boards and national model rules
State boards adopt USP chapters by reference, sometimes with changes or additions such as separate sterile compounding permits, nonresident pharmacy requirements, reporting rules or technician ratios. The NABP Model Act gives states model language. Always check your state's current rule.
When standards overlap
Apply the most stringent requirement that applies. For example, if USP <797> requires surface sampling monthly and the state requires it weekly, sample weekly. If an accreditor requires a label element that USP does not, add it. USP chapters are minimum standards, and stricter state law, CoPs, accreditation standards and the facility's own SOPs are layered on top.
Under CDC injection safety guidance, how should multiple-dose vials be handled?
They may be taken to any bedside and used for several patients during a shift
They may be refilled from larger containers to reduce waste
They should be used like single-dose vials and discarded after one entry
They should be dedicated to a single patient whenever possible; if used for more than one patient, they are kept in a centralized medication area and never enter the immediate patient treatment area
An OR pharmacist is updating the policy on labeling syringes and basins on the sterile field. Under The Joint Commission's current hospital framework, where does this labeling requirement now sit?
It was dropped in 2026 and is now optional
Only in CMS rules, since The Joint Commission no longer addresses medication labeling
Only in USP <797>, which governs operating room labeling
In the National Performance Goals, which replaced the National Patient Safety Goals on January 1, 2026 and keep the requirement to label all medications and solutions on and off the sterile field
A state's sterile compounding rule requires surface sampling of classified areas weekly, but the facility makes only Category 2 CSPs, for which USP <797> requires monthly sampling. What should the facility do?
Sample monthly, because USP <797> takes precedence over state law
Ask the accreditor to pick one frequency
Sample every 6 months, since the chapters conflict
Sample weekly, because when requirements overlap the most stringent applicable one must be met; USP <797> is a minimum
Sections you finish are checked off in the contents.